TNFSF10 and plasma cell myeloma: It has been demonstrated that, by binding to a TNF-related apoptosis-inducing ligand (TRAIL), osteoprotegerin represents a paracrine survival factor by preventing drug-induced apoptosis in myeloma cells [59,60].